The efficacy of immunomodulating therapy in patients with chronic cholestatic liver diseases
Petrunia, A.M.; Enenko, I.A.
Likars'ka Sprava 1996(3-4): 125-127
1996
ISSN/ISBN: 1019-5297 PMID: 9035846 Document Number: 455892
The use is studied of the immunomodulating agents splenin and vilosen in a combined therapy of 93 patients with chronic cholestatic disorders of the liver. The above drug combination was found to have a positive effect on both the immune status and condition of microhemodynamics, with the clinical parameters getting improved, duration of remission lengthened.
Document emailed within 1 workday
Related Documents
Cirera, I. 2000: Recurrence of chronic cholestatic liver diseases following liver transplantation Gastroenterologia y Hepatologia 23(Suppl 1): 77-80Leuschner, U. 1998: Cholestatic liver diseases--diagnosis and therapy. 3: Therapy of primary biliary cirrhosis Fortschritte der Medizin 116(1-2): 37-39
Loza, E.A. 1986: Efficacy of the endobronchial therapy of patients with chronic nonspecific diseases of the lungs Vrachebnoe Delo 4: 56-57
Bliuger, A.F.; Maksimova, L.A.; Kartashova, O.I.; Briedis, L.P. 1976: Outcome of chronic cholestatic lesions of the liver (mechanisms of development of biliary liver cirrhosis) Terapevticheskii Arkhiv 48(9): 20-24
Stellon, A.J.; Davies, A.; Compston, J.; Williams, R. 1985: Osteoporosis in chronic cholestatic liver disease Quarterly Journal of Medicine 57(223): 783-790
Skalyga, I.M.; Zhigarenko, N.I. 1998: The efficacy of enterosorbents and antioxidants in the treatment of chronic liver diseases of alcoholic etiology Likars'ka Sprava 5: 93-95
Stiehl, A. 1993: Treatment of cholestatic liver diseases with phenobarbital and ursodeoxycholic acid Zeitschrift für Gastroenterologie 31(Suppl 2): 129-130
Dincsoy, H.P.; Saelinger, D.A. 1982: Haloperidol-induced chronic cholestatic liver disease Gastroenterology 83(3): 694-700
Shepet'ko, E.N.; Bychkova, N.G.; Garmash, D.A.; Kurbanov, A.K. 2011: Efficacy of the immunomodulating therapy in complex treatment of gastric cancer complicated by acute hemorrhage using radical operations Klinichna Khirurhiia 6: 15-18
Soboleva, L.A.; Shul'dyakov, A.A.; Bulkina, N.V. 2015: Efficacy of Cycloferon Liniment in the Combined Treatment of Chronic Gingivitis in Patients with Chronic Infectious Diseases Eksperimental'naia i Klinicheskaia Farmakologiia 78(7): 41-44
Gushcha, A.L.; Tarasenko, S.V.; Fedoseev, A.V.; Sokolova, S.N. 1996: The antioxidant therapy of cholestatic liver depression in diabetics Anesteziologiia i Reanimatologiia 1: 13-18
Vetter, C. 2003: Chronic liver diseases: what physicians and patients hope for. new strategies against liver cell death MMW Fortschritte der Medizin 145(26): 10
Vleggaar, F.P.; Van Ooteghem, N.A.; Van Buuren, H.R.; Van Berge Henegouwen, G.P. 2000: Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders Scandinavian Journal of Gastroenterology. Suppl 232: 86-92
Baussan, C.; Cresteil, D.; Gonzales, E.; Raynaud, N.; Dumont, M.; Bernard, O.; Hadchouel, M.; Jacquemin, E. 2004: Genetic cholestatic liver diseases: the example of progressive familial intrahepatic cholestasis and related disorders Acta Gastro-Enterologica Belgica 67(2): 179-183
Dinler, G.; Koçak, N.; Yüce, A.; Gürakan, F.; Ozen, H. 1999: Ursodeoxycholic acid therapy in children with cholestatic liver disease Turkish Journal of Pediatrics 41(1): 91-98
Zhang, Y.Y.; Guo, L.S.; Li, L.; Zhang, Y.D.; Hao, L.J.; Hansson, B.G.; Nordenfelt, E. 1993: Hepatitis B virus DNA detected by PCR in sera and liver tissues of Chinese patients with chronic liver diseases Chinese Medical Journal 106(1): 7-12
Toda, G.; Ikeda, Y.; Hashimoto, N.; Yamazaki, M.; Torii, M.; Oka, H. 1983: Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases Clinical and Experimental Immunology 54(3): 661-670
Jabłońska-Kaszewska, I.; Bielawski, W.; Zółtowska, A.; Zamorska, I.; Fenc, E. 1982: HBs and HBc antigens in the liver of patients with chronic liver diseases Polski Tygodnik Lekarski 37(19-20): 541-544
Sharma, Y.R.; Miah, A.R.; Saha, S.K.; Mohammed, S.; Rahman, M.; Roy, P.K.; Hasan, M. 2004: A study on efficacy of lamivudine therapy in decompensated cirrhosis of liver due to chronic hepatitis B virus infection Nepal Medical College Journal: Nmcj 6(2): 106-111
Trybrat, T.A. 1999: The effect of combined therapy with a salt solution of Poltava bischofite on the clinical status, adaptive hormone level and blood rheology in patients with ischemic heart disease and chronic inflammatory diseases of the liver and gallbladder Likars'ka Sprava 2: 120-123